Qilian International Holding Group Ltd. stock is up 32.62% since 30 days ago. The next earnings date is Apr 17, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 December’s closed higher than November.
Qilian International Holding Group Limited engages in the research, development, and production of active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company offers Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human. In addition, it offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases.